CELYAD ONCOLOGY Slumps 9% As Market Ends Session: Is Trouble Brewing?

(VIANEWS) – CELYAD ONCOLOGY (BEL 20: CYAD.BR) fell 9.81% to EUR0.96 at 15:18 EST Monday afternoon after four straight sessions of gains, while the BEL 20 was down 0.35% at EUR3,670.13, signalling an overall downward trend for today’s trading session. About CELYAD ONCOLOGY Celyad Oncology SA is a clinical-stage biopharmaceutical company focused on the research…

Read More

PORCELEYNE FLES Stocks Plunge 9% Amid Monday Session Close

(VIANEWS) – As shares of PORCELEYNE FLES (PORF.AS) experienced another sharp drop on Monday’s trading session – taking them down 9.35% to EUR12.60 – further exacerbating last Friday’s slump, although the AEX-Index rose 0.68% overall reaching EUR751.111. This may indicate an uncertain trading session going forward. About PORCELEYNE FLES B.V. Delftsch Aardewerkfabriek “De Porceleyne Fles…

Read More